Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

No 1 (2003)

Articles

The 80th anniversary of the journal "Urologiya"

Lopatkin N.A., Gorilovsky L.M.
Urologiia. 2003;(1):3-6
pages 3-6 views

The results of 5-year screening for prostatic cancer

Matveev B.P., Komarova L.E., Bukharkin B.V., Sholokhov V.N., Kadagidze Z.G., Cheban N.L., Lepedatu P.I., Shelepova V.M., Peredery N.V., Lomakin N.N.

Abstract

The results of 5-year screening (1996-2000) for prostatic cancer in 1129 males 40 to 80 years of age are presented. The examination included: measurement of blood levels of prostate-specific antigen (PSA), finger rectal examination, transrectal ultrasonic examination (TRUE) and, on demand, biopsy of the prostatic gland. Prostatic cancer was diagnosed in 1.5, 2.2 and 16% patients having PSA levels of 0-4.0, 4.0-10.0 and 10.0-30.0% ng/ml, respectively. At finger rectal examination prostatic cancer was suspected in 8% examinees, only in 33% of them the diagnosis was verified morphologically. By TRUE evidence 7% examinees were suspected and in 44.3% of them prostatic cancer was confirmed. Thus, biopsy proved necessary in 172 cases of 1129 examinees. In 64 (5.7%) males prostatic cancer was diagnosed and confirmed. Early prostatic cancer in the screened men and those consulted in the outpatient department of the National Cancer Research Center was detected in 77.7 and 22% men, respectively. The conclusion is made that men over 50 years of age should undergo prophylactic examination of the prostatic gland once a year.
Urologiia. 2003;(1):6-10
pages 6-10 views

Screening for prostatic cancer

Pushkar D.Y., Govorov A.V., Bormotin A.V.

Abstract

The discussion covers different aspects of application of programs of early prostatic cancer diagnosis. Arguments for and against the screening are presented. The existing methods of early prostatic cancer diagnosis are reviewed. How to improve the technique of taking prostatic biopsy is shown.
Urologiia. 2003;(1):10-15
pages 10-15 views

Results of the treatment of irritative symptoms and urinary retention in patients one year after radical retropubic prostatectomy

Veliev E.I., Petrov S.B.

Abstract

Aim. To assess function of urinary retention and irritative symptoms from the lower urinary tracts in patients after radical prostatectomy for local prostatic cancer. Material and methods. From November 1997 to May 2001 radical prostatectomy was performed in 181 patients. One year after the operation 86 patients with pTlc-T2b filled in the questionnaire on urinary retention (UR) and irritative symptoms. Results. One year after radical prostatectomy complete UR was registered in 76% of the patients, partial UR in 20.5% and unsatisfactory UR in 3.5%. Uroflowmetrical and ultrasound investigations, urine seeding made possible to select 16 patients with irritative symptoms. 11 patients of this group received alpha-adrenoblocker terazosin with a good response. Conclusion. One year after radical prostatectomy UR (complete or partial) was observed in 96.5% patients. Irritative symptoms unrelated to stricture of vesicourethral anastomosis and inflammation can be eliminated by administration of terazosin.
Urologiia. 2003;(1):15-17
pages 15-17 views

Urinary tract occlusion _ a principal cause of some urolithiasis complications

Yanenko E.K., Rumyantsev V.B., Safarov R.M., Stupak N.V.

Abstract

Urinary tract occlusion in urolithiasis is a serious complication which provokes an attack of acute obstructive pyelonephritis. The infected urine aggravates this infectious-inflammatory process and endangers bacterial shock. Etiopathogenesis of this shock is outlined and modern approaches to its management are described.
Urologiia. 2003;(1):17-21
pages 17-21 views

Residual nephroliths and their treatment

Dzeranov N.K., Beshliev D.A., Golovanov S.A., Moskalenko S.A., Sinyukhin V.N., Aliev M.B.

Abstract

416 case histories of patients with different forms of urolithiasis aged 6 to 70 years who had undergone sectional nephrolithotomy (83, 19.9%), pyelonephrolithotomy (24, 5.8%), pyelolithotomy (146, 35.1%), percutaneous nephrolithotomy (163, 39.9%) were analysed. Residual nephroliths occurred in 108 (25.9%) patients. 98 of them were subjected to extracorporeal lithotripsy (ELT). To determine minimal possible interval between the operation and ELT, changes in the levels of lipid peroxidation products and concentration of aglutatliione-S-aminotransfcrase were studied. The results allowed the authors to optimize ELT after operative interventions for uroliths. In the course of 206 ELT sessions the residual uroliths were destroyed in 96 (97.9%) patients. After one session a complete fragmentation was achieved in 19 (19.4%) patients, after two sessions - in 64 (65.3%) patients, after three sessions and more - in 15 (15.3%). Pyoinflammatory complications developed in 8 (8.2%) patients while retrospectively such complications were encountered in 16 of 50 patients (32%). One month after ELT, the control examination found neither nephroliths nor their fragments in 85 (86.7%) patients, in patients with large and multiple stones elimination rate 1.5 months after the treatment was 69.5%. It is inferred that ELT is an effective method of residual uroliths elimination and is a method of choice in the treatment of such patients.
Urologiia. 2003;(1):21-26
pages 21-26 views

Some features of recovery of upper urinary tract urodynamics after surgical treatment of vesicoureteral dysplasia in children

Panikratov K.D., Pochernikov D.G., Strelnikov A.I.

Abstract

Urodynamics of the upper urinary tract (UUT) was examined in 327 children aged 1.5 months to 15 years with congenital vesicoureteral reflux (VUR) dysplasia treated surgically. 230 patients were followed up for 1 to 20 years. Staging of chronic disorders of UUT urodynamics is thought to be the key criterion of objective assessment of VUR effective surgical treatment . The better long-term treatment outcomes are the earlier the disease was diagnosed and corrected. Early defects of urodynamics in the absence of marked dilatation of the ureter are better corrected by Lich-Gregoir operation which is physiological, low traumatic, technically available and most effective (97% of favourable long-term outcomes). Ureterocystoneostomy by Politano-Leadbetter (in modification of the authors) is indicated in urodynamic disorders stage III and marked ureteral dilatation as providing improvement of urodynamics or stabilization in 93.7% patients.
Urologiia. 2003;(1):27-31
pages 27-31 views
pages 31-34 views

Structural-and-functional damage to cellular membranes in deficiency of vitamins A, E, B2, B6, and PP in children with calculous pyelonephritis

Atadzhanov U.Z., Utegenov N.U.

Abstract

Lipids were studied in 150 patients with nephrolithiasis, calculous pyelonephritis; enzymes, LPO products, phospholipase in HI patients; vitamins A and E in 136 patients, vitamins B2, B6 and PP in 146 patients in the course of the disease, at admission and after treatment. In acute purulent and aggravated chronic calculous pyelonephritis lysophospholipids levels rose manifolds. Activation of LPO products, phospholipase, organ-specific enzymes is closely associated with low provision of vitamins A, E, B2, B6, PP. Deficiency of these vitamins ranged from 76.8 to 94.6% in acute purulent calculous pyelonephritis in all the patients.
Urologiia. 2003;(1):35-41
pages 35-41 views

Establishment of pyelocystoanastomosis in ureteral obliteration after transplantation of the kidney

Perlin D.V., Darenkov S.P., Petrova M.V., Anashkin V.A., Okhobotov D.A., Alexandrov I.V.

Abstract

Reconstruction of the urinary tract because of ureteral stricture after kidney transplantation is a serious problem. In development of obliteration of the recipient's ureter near anastomosis and in the absence of own ureters reconstruction is made by pyelocystoanastomosis. A case is reported of a successful use of this method in reconstruction of the urinary tract. Preoperative preparation includes transcutaneous nephrostomy. Sometimes Boary flap is used. The arising reflux had insignificant effect on the transplant's function.
Urologiia. 2003;(1):41-43
pages 41-43 views

Long-term use of ovestin in postmenopausal women suffering from urinary incontinence

Dyakov V.V., Godunov B.N., Grozdev M.Y.

Abstract

The aim of the study was to improve diagnosis and treatment of women suffering from clinical manifestations of urogenital atrophy in menopause: stress and urgent urine incontinence, disturbances of urination, recurrent infections of the lower urinary tracts. A total of 237 menopausal women were treated for urogenital atrophy for four years. The age of the patients ranged from 51 to 78 years (mean age 64.5 years). After treatment with ovestin they were followed up for 1 to 2.1 years. It was found that stress incontinence is more common in young women, older females suffer more frequently from urgent and imperative incontinence. Ovestin, as a local replacement therapy, relieved symptoms within the first several days of treatment, the complaints disappeared completely after 25 days of ovestin intake. Side effects (nausea, head ache, breast discomfort) occurred rarely, were mild and disappeared within the first two weeks of the treatment. The conclusion is made that urogenital atrophy is a common disease of postmenopausal women arising as a result of lacking estrogenization of the vagina and adjacent tissues. Urogenital atrophy manifests as stress and urgent urinary incontinence, disurea and' recurrent infection of the lower urinary tracts. Ovestin therapy should be given for at least 1.5 months. In positive effect the duration of the treatment is not limited.
Urologiia. 2003;(1):43-46
pages 43-46 views

Treatment of stable dysuria in women

Neimark A.I., Chulyukova I.I., Mazyrko A.V., Neimark B.A., Blinova O.B.

Abstract

The authors analyse treatment results for 88 women suffering from stable dysuria (SD). 44 of them with diagnosis "proliferative cystitis" underwent TUR of the bladder mucosa. The rest were treated conventionally. Biopsy of the bladder was made in all the patients. It is shown that mechanisms of SD development lies in that developing metaplasia of the squamous epithelium prevents close contacts between the surface cells leading to urine penetration into the submucous layer. This provokes frequent and painful micturition. The area of the bladder triangle contains vaginal epithelium (embryological) which changes according to the menstrual phases. Dysuria is more pronounced in the premenstrual period, i.e. in the period of marked desquamation of the squamous epithelial. Desquamation of the surface layer of metaplastic squamous epithelium cells and its thinning ease urine diffusion via intercellular space to the nerves and muscles of the bladder detrusor, thus deteriorating clinical symptoms. Thus, pain in full bladder results from functional failure of metaplastic multilayer squamous epithelium. To eradicate SD in such a situation, TUR of the bladder is recommended.
Urologiia. 2003;(1):46-49
pages 46-49 views

Dehydroepiandrosterone (DHEA) and sexual function in men with chronic prostatitis

Vakina T.N., Shutov A.M., Shalina S.V., Zinovyeva E.G., Kiselev I.P.

Abstract

The aim of this study was to determine relationships between the level of DHEA-sulfate (DHEA-S), an erectile function and libido in men with chronic prostatitis. 53 patients (mean age 44.6±12.0; range 21-68 years) with chronic prostatitis were studied. Libido and erection were estimated and patients were divided into n»o groups according to their sexual dysfunction: 21 patients with severe sexual dysfunction (SSD) and 32 patients with mild sexual dysfunction (MSD). Testosterone, prolactin and DHEA-S were detected by ELISA. SSD patients had a lower testosterone level than patients with MSD (11.8±4.6 vs 14.8±5.9 nmol/1, respectively, p = 0.04) and DHEA-S (1.7+0.8 vs 2.5+1.2 microg/ml, respectively, p = 0.01). There was a negative correlation between the age of the patents and an erectile function (r = -0.70; p < 0.001), age and libido ir = -0.57; p < 0.001). The negative correlation was revealed between DHEA-S and age (r = -0.59; p < 0.001). A positive correlation »as between DHEA-S and an erectile function (r = 0.45. p = O.OOi i. There was no correlation between DHEA-S and serum testosterone te%ei t.r = 0.10; p = 0.5). Multiple regression analysis showed an independent positive correlation between DHEA-S and erectile function in patients with chronic prostatitis (p = 0.28; p = 0.02: R; = 0.401 The findings show that erectile dysfunction independently from aee s associated with a lower level of serum DHEA-S in patients with chronic prostatitis.
Urologiia. 2003;(1):49-52
pages 49-52 views

Sexual correction in testicular feminization syndrome

Dzhavad-Zade M.D., Guseinov E.Y., Guseinova T.T., Magarramov A.D.

Abstract

From 1993 to 2000 the authors observed 10 patients with testicular feminization. In spite of existent highly informative methods, early diagnosis of the genesis of abnormal sexual differentiation is not easy, it requires time .Treatment policy varied with the form of testicular feminization. In a complete form (6 patients), bilateral ventrofixation of the gonads (ovotestis) was made, in incomplete form (4 patients) male gonads were removed with subsequent replacement hormonotherapy. Correction of the external genitalia consisted in amputation of the hypertrophic clitoris with creation of the femaletype external genitalia. It is emphasized that in incomplete testicular feminization surgical correction should be started before the appearance of secondary sexual characters to raise effectiveness of hormone treatment in formation of a female genotype.
Urologiia. 2003;(1):52-55
pages 52-55 views

Urogenital chlamydial infection: treatment with wilprafen

Yakubovich A.I., Chuprin A.E., Rakitin D.A.

Abstract

Antibiotic wilprafen (josamycin) was given in a dose 500 mg per os two times a day for 15 days to 30 male patients with a long history of chronic Chlamydia trachomatis infection (CTI) treated ineffectively. The control examination has not detected Chlamydia in 29 (96.5%) patients. The results demonstrate high efficacy of the drug wilprafen in the treatment of patients with urogenital CTI.
Urologiia. 2003;(1):55-58
pages 55-58 views
pages 59-61 views
pages 62-63 views
pages 63-63 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies